AXSOME THERAPEUTICS, INC. Long-Term Debt, Maturity, Year One
AXSOME THERAPEUTICS, INC. (AXSM) had Long-Term Debt, Maturity, Year One of $2.67 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2020-03-12
- 2019-12-31: Long-Term Debt, Maturity, Year One $2.67M.
- 2017-12-31: Long-Term Debt, Maturity, Year One $3.33M.
- 2017-03-31: Long-Term Debt, Maturity, Year One $277.78K.
- 2016-12-31: Long-Term Debt, Maturity, Year One $277.78K.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2019-12-31 | $2.67M 10-K · filed 2020-03-12 |
| 2017-12-31 | $3.33M 10-K · filed 2018-03-07 |
| 2017-03-31 | $277.78K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $277.78K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |